UICC drops the ball in the 8th edition TNM staging of urological cancers
Histopathology
.
2017 Jul;71(1):5-11.
doi: 10.1111/his.13200.
Authors
Brett Delahunt
1
,
Lars Egevad
2
,
Hemamali Samaratunga
3
,
Murali Varma
4
,
Clare Verrill
5
,
John Cheville
6
,
Glen Kristiansen
7
,
Catherine Corbishley
8
,
Daniel M Berney
9
Affiliations
1
Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
2
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
3
Aquesta Uropathology and University of Queensland, Brisbane, Queensland, Australia.
4
Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK.
5
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
6
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
7
Institute of Pathology, University Hospital Bonn, Bonn, Germany.
8
Department of Cellular Pathology, St George's Healthcare NHS Foundation Trust, London, UK.
9
Department of Molecular Oncology, Barts Cancer Institute, St Bartholomew's Hospital, Queen Mary University of London, London, UK.
PMID:
28239904
DOI:
10.1111/his.13200
No abstract available
Publication types
Editorial
MeSH terms
Humans
Medical Oncology / standards*
Neoplasm Staging / standards*
Practice Guidelines as Topic / standards*
Societies, Medical
Urologic Neoplasms / classification*
Urologic Neoplasms / pathology*